Ependymoma in childhood: Prognostic factors, extent of surgery, and adjuvant therapy

Journal of Neurosurgery

Volumn 97, Issue 4, 2002, Pages 827-835

  Van Veelen Vincent, Marie Lise C ^a   Pierre Kahn, Alain ^a   Kalifa, Chantale ^a   Sainte Rose, Christian ^a   Zerah, Michel ^a   Thorne, John ^a   Renier, Dominique ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Chemotherapy; Children; Ependymoma; Radiotherapy; Resection; Tumor recurrence

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; PROCARBAZINE; VINCRISTINE;

ADJUVANT THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; COMPUTER ASSISTED TOMOGRAPHY; EPENDYMOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURGICAL TECHNIQUE; SURVIVAL; TUMOR RECURRENCE;

EID: 0036801605     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2002.97.4.0827     Document Type: Article

References (42)

1. Awaad YM, Allen JC, Miller DC, et al: Deferring adjuvant therapy for totally resected intracranial ependymoma. Pediatr Neurol 14:216-219, 1996
2. Bennetto L, Foreman N, Hardin B, et al: Ki-67 immunolabeling index is a prognostic indicator in childhood posterior fossa ependymomas. Neuropathol Appl Neurobiol 24:434-440, 1998
3. Bouffet E, Perilongo G, Canete A, et al: Intracranial ependymomas in children: A critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol 30:319-331, 1998
4. Chiu JK, Woo Sy, Ater J, et al: Intracranial ependymoma in children: Analysis of prognostic factors. J Neurooncol 13:283-290, 1992
5. Dohrmann GJ, Farwell JR, Hannery JT: Ependymomas and ependymoblastomas in children. J Neurosurg 45:273-283, 1976
6. Duffner PK, Horowitz ME, Krischer JP, et al: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328:1725-1731, 1993
7. Evans AE, Anderson JR, Lefkowitz-Boudreaux IB, et al: Adjuvant chemotherapy of childhood posterior fossa ependymoma: Cranio-spinal irradiation with or without adjuvant CCNU, vincristine and prednisone: A Childrens Cancer Group study. Med Pediatr Oncol 27:8-14, 1996
8. Figarella-Branger D, Civatte M, Bouvier-Labit C, et al: Prognostic factors in intracranial ependymomas in children. J Neurosurg 93:605-613, 2000
9. Finlay JL, Boyett JM, Yates AJ, et al: Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol 13:112-123, 1995
10. Foreman NK, Love S, Gill SS, et al: Second-look surgery for incompletely resected fourth ventricle ependymomas: Technical case report. Neurosurgery 40:856-860, 1997
11. Foreman NK, Love S, Thorne R: Intracranial ependymomas: Analysis of prognostic factors in a population-based series. Pediatr Neurosurg 24:119-125, 1996
12. Friedman HS, Krischer JP, Burger P, et al: Treatment of children with progressive or recurrent brain tumors with carboplatin of iproplatin: A Pediatric Oncology Group randomized phase II study. J Clin Oncol 10:249-256, 1992
13. Gerszten PC, Pollack IF, Martinez AJ, et al: Intracranial ependymomas of childhood. Lack of correlation of histopathology and clinical outcome. Pathol Res Pract 192:515-522, 1996
14. Goldwein JW, Glauser TA, Packer RJ, et al: Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors. Cancer 66:557-563, 1990
15. Grill J, Kalifa C, Doz F, et al: A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study. Pediatr Neurosurg 25:7-12, 1996
16. Grill J, Le Deley MC, Gambarelli D, et al: Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: A multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol 19:1288-1296, 2001
17. Hamilton RL, Pollack IF: The molecular biology of ependymomas. Brain Pathol 7:807-822, 1997
18. Healey EA, Barnes PD, Kupsky WJ, et al: The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery 28:666-672, 1991
19. Horn B, Heideman R, Geyer R, et al: A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. J Pediatr Hematol Oncol 21:201-211, 1999
20. Hukin J, Epstein F, Lefton D, et al: Treatment of intracranial ependymoma by surgery alone. Pediatr Neurosurg 29:40-45, 1998
21. Ikezaki K, Matsushima T, Inoue T, et al: Correlation of microanatomical localization with postoperative survival in posterior fossa ependymomas. Neurosurgery 32:38-44, 1993
22. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3:255-268, 1993
23. Lyons MK, Kelly PJ: Posterior fossa ependymomas: report of 30 cases and review of the literature. Neurosurgery 28:659-665, 1991
24. Mason WP, Goldman S, Yates AJ, et al: Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma - A report of the Children's Cancer Group. J Neurooncol 37:135-143, 1998
25. Nazar GB, Hoffman HJ, Becker LE, et al: Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg 72:408-417, 1990
26. Needle MN, Goldwein JW, Grass J, et al: Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer 80:341-347, 1997
27. Papadopoulos DP, Giri S, Evans RG: Prognostic factors and management of intracranial ependymomas. Anticancer Res 10:689-692, 1990
28. Perilongo G, Massimino M, Sotti G, et al: Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-Oncology Group. Med Pediatr Oncol 2:79-85, 1997
29. Pollack IF, Gerszten PC, Martinez AJ, et al: Intracranial ependymomas of childhood: Long-term outcome and prognostic factors. Neurosurgery 37:655-667, 1995
30. Prayson RA: Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry. Ann Diagn Pathol 3:11-18, 1999
31. Ritter AM, Hess KR, McLendon RE, et al: Ependymomas: MIB-I proliferation index and survival. J Neurooncol 40:51-57, 1998
32. Robertson PL, Zeltzer PM, Boyett JM, et al: Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: A report of the Children's Cancer Group. J Neurosurg 88:695-703, 1998
33. Ross GW, Rubinstein LJ: Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 70:31-36, 1989
34. Rousseau P, Habrand JL, Sarrazin D, et al: Treatment of intracranial ependymomas of children: Review of a 15-year experience. Int J Radiat Oncol Biol Phys 28:381-386, 1994
35. Sala F, Talacchi A, Mazza C, et al: Prognostic factors in childhood intracranial ependymomas: The role of age and tumor location. Pediatr Neurosurg 28:135-142, 1998
36. Schiffer D, Chio A, Cravioto H, et al: Ependymoma: Internal correlations among pathological signs: The anaplastic variant. Neurosurgery 29:206-210, 1991
37. Schiffer D, Chio A, Giordana MT, et al: Histologic prognostic factors in ependymoma. Childs Nerv Syst 7:177-182, 1991
38. Schild SE, Nisi K, Scheithauer BW, et al: The results of radiotherapy for ependymomas: The Mayo Clinic experience. Int J Radiat Oncol Biol Phys 42:953-958, 1998
39. Schwartz TH, Kim S, Glick RS, et al: Supratentorial ependymomas in adult patients. Neurosurgery 44:721-731, 1999
40. Shaw EG, Evans RG, Scheithauer BW, et al: Postopertive radiotherapy of intracranial ependymoma in pediatric and adult patients. Int J Radiat Oncol Phys 13:1457-1462, 1987
41. Vanuytsel L, Brada M: The role of prophylactic spinal irradiation in localized intracranial ependymoma. Int J Radiat Oncol Biol Phys 21:825-830, 1991
42. von Haken MS, White EC, Daneshvar-Shyesther L, et al: Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas. Genes Chromosomes Cancer 17:37-44, 1996